Skip to main content
New Year’s Sale — Build a balanced news diet with 40% off Vantage
Get Started
SubscribeLogin
Published • loading... • Updated

Takeda Pharmaceutical Company Limited (TAK) Q3 2023 Earnings Call Transcript

Summary by Ground News
Takeda Pharmaceutical Company Limited (NYSE:TAK) Q3 2023 Earnings Conference Call February 2, 2023 5:30 AM ET Company Participants Christopher OReilly - Head, Investor Relations Christophe Weber - President and Chief Executive Officer Andy Plump - President, R&D Costa Saroukos - Chief Financial Officer Ramona Sequeira - President,. Global Portfolio Division Conference Call Participants Hidemaru Yamaguchi - Citigroup Motoya Koutani - Nomura Securities Seiji Wakao - JPMorgan Shinichiro Muraoka - Morgan Stanley

1 Articles

Seeking AlphaSeeking Alpha
Lean Right

Takeda Pharmaceutical Company Limited (TAK) Q3 2023 Earnings Call Transcript

Takeda Pharmaceutical Company Limited (NYSE:NYSE:TAK) Q3 2023 Earnings Conference Call February 2, 2023 5:30 AM ETCompany ParticipantsChristopher O’Reilly - Head, Investor...

·United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Right
100% Right

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Seeking Alpha broke the news in United States on Friday, February 3, 2023.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal